Three-Phase Planar Bone Scintigraphy

Overview

Three-phase planar bone scintigraphy is a nuclear medicine imaging technique that evaluates bone and surrounding tissue by tracking a radiopharmaceutical, typically a technetium-99m-labelled diphosphonate, through three sequential phases after injection: an early blood-flow phase, a blood-pool phase reflecting soft-tissue perfusion, and a delayed phase showing uptake into bone. By comparing these phases, the study distinguishes processes affecting blood flow and soft tissue from those involving bone metabolism, which makes it useful for detecting and characterising conditions such as infection, fractures, tumours, inflammatory and metabolic bone disease, and complications of orthopaedic procedures. Its sensitivity to changes in bone turnover allows abnormalities to be identified, often before they are visible on conventional radiographs. This page gathers peer-reviewed, open-access research relevant to bone imaging within the scope of Radiation and Nuclear Medicine. On-topic context includes an overview of imaging modalities in the evaluation of bone allograft viability, which surveys the imaging approaches used to assess bone status and integrity, the broader domain to which three-phase bone scintigraphy belongs. Together with the journal's coverage of nuclear medicine and diagnostic imaging, this material reflects the role of scintigraphic techniques in assessing bone perfusion and metabolism for the diagnosis and monitoring of skeletal disease.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics